📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa. (2023)

First Author: Olupot-Olupot P

Attributed to: MICA: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2022017051

PubMed Identifier: 36375125

Publication URI: http://europepmc.org/abstract/MED/36375125

Type: Journal Article/Review

Volume: 141

Parent Publication: Blood

Issue: 12

ISSN: 0006-4971